Publication | Closed Access
Carmustine (BCNU) plus Teniposide (VM26) in Recurrent Malignant Glioma
21
Citations
16
References
2014
Year
Our data do not support the application of BCNU/VM26 in patients with late stages of recurrent GBM.
| Year | Citations | |
|---|---|---|
Page 1
Page 1